|
|
||||||||
In Cuba, 2 epidemics of dengue virus occurred: 1 caused by DEN-1 in 1977 and 1 caused by DEN-2 in 1981. The latter was associated with cases of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). To study viral risk factors for DHF/DSS, a retrospective seroepidemiological survey was conducted in Cerro, a densely populated district in Havana City. The prevalence of plaque reduction neutralizing antibodies to DEN-1 and DEN-2 viruses was measured in 1,295 individuals (children and adults). Of these, 43.7% were immune to DEN-1 virus and 23.6% to DEN-2 virus. Of those individuals who were immune, 26.1% were immune to DEN-1 virus only, 6% to DEN-2 virus only, and 17.6% to both viruses. The DEN-2 virus infection rate in DEN-1 immune individuals was 3.8 times higher than in non-immune individuals. The 5 DHF/DSS cases in the sample had evidence of DEN-1 virus plus DEN-2 virus infections. Three were children and 2 were young adults. No cases were found in individuals infected with DEN-1 virus or DEN-2 virus only. Children infected by DEN-1 virus followed by DEN-2 virus had a high risk of acquiring DHF/DSS. Blacks and whites were equally infected with DEN-1 and DEN-2 viruses.
This article has been cited by other articles:
![]() |
I.-K. Lee, J.-W. Liu, and K. D. Yang Clinical and Laboratory Characteristics and Risk Factors for Fatality in Elderly Patients with Dengue Hemorrhagic Fever Am J Trop Med Hyg, August 1, 2008; 79(2): 149 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lai, W.-Y. Tsai, S.-R. Lin, C.-L. Kao, H.-P. Hu, C.-C. King, H.-C. Wu, G.-J. Chang, and W.-K. Wang Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II J. Virol., July 1, 2008; 82(13): 6631 - 6643. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thomas, O. Verlaeten, A. Cabie, S. Kaidomar, V. Moravie, J. Martial, F. Najioullah, Y. Plumelle, C. Fonteau, P. Dussart, et al. Influence of the Dengue Serotype, Previous Dengue Infection, and Plasma Viral Load on Clinical Presentation and Outcome During a Dengue-2 and Dengue-4 Co-Epidemic Am J Trop Med Hyg, June 1, 2008; 78(6): 990 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boonnak, B. M. Slike, T. H. Burgess, R. M. Mason, S.-J. Wu, P. Sun, K. Porter, I. F. Rudiman, D. Yuwono, P. Puthavathana, et al. Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection J. Virol., April 15, 2008; 82(8): 3939 - 3951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamanaka, S. Kosugi, and E. Konishi Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels J. Virol., January 15, 2008; 82(2): 927 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Cordeiro, A. M. Silva, C. A. A. Brito, E. J. M. Nascimento, M. C. F. Magalhaes, G. F. Guimaraes, N. Lucena-Silva, E. M. F. de Carvalho, and E. T. A. Marques Jr Characterization of a Dengue Patient Cohort in Recife, Brazil Am J Trop Med Hyg, December 1, 2007; 77(6): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |